Petra Ročić

3.3k total citations · 1 hit paper
56 papers, 2.7k citations indexed

About

Petra Ročić is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Petra Ročić has authored 56 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Physiology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Petra Ročić's work include Nitric Oxide and Endothelin Effects (16 papers), Hormonal Regulation and Hypertension (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). Petra Ročić is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Hormonal Regulation and Hypertension (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). Petra Ročić collaborates with scholars based in United States, Canada and United Kingdom. Petra Ročić's co-authors include Kathy K. Griendling, Yoshihiro Taniyama, David S. Weber, Puvi Seshiah, Rebecca Hutcheson, Pamela A. Lucchesi, William M. Chilian, Michal L. Schwartzman, Christopher Kolz and Katalin Szöcs and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Petra Ročić

55 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin II Stimulation of NAD(P)H Oxidase Activity

2002 609 citations Puvi Seshiah, David S. Weber et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Petra Ročić United States	27	1.2k	780	751	395	362	56	2.7k
Ana Fortuño Spain	35	851 0.7×	1.2k 1.5×	841 1.1×	575 1.5×	347 1.0×	68	3.2k
Radko Komers United States	33	1.2k 1.1×	689 0.9×	786 1.0×	210 0.5×	666 1.8×	102	3.6k
Gorka San José Spain	30	758 0.7×	906 1.2×	1.3k 1.7×	568 1.4×	309 0.9×	51	3.1k
Yoshihiro Taniyama Japan	22	1.4k 1.2×	1.1k 1.5×	676 0.9×	679 1.7×	448 1.2×	32	3.3k
Masao Kakoki United States	31	1.1k 0.9×	689 0.9×	709 0.9×	300 0.8×	477 1.3×	53	3.0k
Jinah Hwang South Korea	18	1.0k 0.9×	1.0k 1.3×	582 0.8×	565 1.4×	177 0.5×	40	2.7k
Andrea Hartner Germany	31	1.1k 0.9×	416 0.5×	662 0.9×	356 0.9×	509 1.4×	111	3.3k
Allen C. Clermont United States	36	1.8k 1.5×	782 1.0×	645 0.9×	410 1.0×	556 1.5×	77	5.4k
María U. Moreno Spain	27	693 0.6×	671 0.9×	1.1k 1.5×	439 1.1×	238 0.7×	49	2.6k
Clara Di Filippo Italy	25	1.0k 0.9×	453 0.6×	593 0.8×	320 0.8×	426 1.2×	58	2.4k

Countries citing papers authored by Petra Ročić

Since Specialization

Citations

This map shows the geographic impact of Petra Ročić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Ročić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Ročić more than expected).

Fields of papers citing papers by Petra Ročić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Ročić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Ročić. The network helps show where Petra Ročić may publish in the future.

Co-authorship network of co-authors of Petra Ročić

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Ročić. A scholar is included among the top collaborators of Petra Ročić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Ročić. Petra Ročić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soliman, Sahar, et al.. (2025). Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies. Pharmaceuticals. 18(10). 1519–1519.

Ročić, Petra, et al.. (2024). Third-year medical students’ perceptions of confidence and readiness to perform EFAST after training. BMC Medical Education. 24(1). 1493–1493. 1 indexed citations

Ročić, Petra, Peter Bramlage, Olaf Grisk, et al.. (2023). Angiotensin receptor-neprilysin inhibitor improves coronary collateral perfusion. Frontiers in Cardiovascular Medicine. 9. 981333–981333. 1 indexed citations

Ročić, Petra. (2019). Comparison of Cardiovascular Benefits of Bariatric Surgery and Abdominal Lipectomy. Current Hypertension Reports. 21(5). 37–37. 1 indexed citations

Ročić, Petra & Michal L. Schwartzman. (2018). 20-HETE in the regulation of vascular and cardiac function. Pharmacology & Therapeutics. 192. 74–87. 86 indexed citations

Hunter, Ian, Gregory Joseph, Rebecca Hutcheson, et al.. (2018). Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation. Journal of Molecular and Cellular Cardiology. 117. 88–99. 27 indexed citations

Joseph, Gregory, Rebecca Hutcheson, Ian Hunter, et al.. (2016). Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 312(3). H528–H540. 37 indexed citations

Alzoubi, Abdallah, Michie Toba, Kohtaro Abe, et al.. (2013). Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 304(12). H1708–H1718. 86 indexed citations

Stewart, James A., et al.. (2011). MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. Journal of Molecular and Cellular Cardiology. 51(6). 1015–1025. 41 indexed citations

10.

Ročić, Boris, Ariana Znaor, Petra Ročić, David S. Weber, & Marijana Vučić Lovrenčić. (2011). Comparison of antihyperglycemic effects of creatine and glibenclamide in type II diabetic patients. Wiener Medizinische Wochenschrift. 161(21-22). 519–523. 6 indexed citations

11.

Yun, June, Petra Ročić, Yuh Fen Pung, et al.. (2009). Redox-Dependent Mechanisms in Coronary Collateral Growth: The “Redox Window” Hypothesis. Antioxidants and Redox Signaling. 11(8). 1961–1974. 63 indexed citations

12.

Reed, Ryan, et al.. (2009). Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome. American Journal of Physiology-Heart and Circulatory Physiology. 296(6). H1811–H1821. 20 indexed citations

13.

Ročić, Petra, Christopher Kolz, Ryan Reed, Barry J. Potter, & William M. Chilian. (2007). Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H2729–H2736. 61 indexed citations

14.

Toyota, Eiji, David C. Warltier, Tommy A. Brock, et al.. (2005). Vascular Endothelial Growth Factor Is Required for Coronary Collateral Growth in the Rat. Circulation. 112(14). 2108–2113. 117 indexed citations

15.

Weber, David S., Petra Ročić, Karine Laude, et al.. (2004). Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22^phox in vascular smooth muscle. American Journal of Physiology-Heart and Circulatory Physiology. 288(1). H37–H42. 88 indexed citations

16.

Taniyama, Yoshihiro, Masuko Ushio‐Fukai, Hirofumi Hitomi, et al.. (2004). Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. American Journal of Physiology-Cell Physiology. 287(2). C494–C499. 103 indexed citations

17.

Ročić, Petra, Puvi Seshiah, & Kathy K. Griendling. (2003). Reactive Oxygen Species Sensitivity of Angiotensin II-dependent Translation Initiation in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 278(38). 36973–36979. 31 indexed citations

18.

Ročić, Petra, Hanjoong Jo, & Pamela A. Lucchesi. (2003). A role for PYK2 in ANG II-dependent regulation of the PHAS-1-eIF4E complex by multiple signaling cascades in vascular smooth muscle. American Journal of Physiology-Cell Physiology. 285(6). C1437–C1444. 13 indexed citations

19.

Dell’Italia, Louis J., Petra Ročić, & Pamela A. Lucchesi. (2002). Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease. Current Problems in Cardiology. 27(1). 6–36. 11 indexed citations

20.

Ročić, Petra & Pamela A. Lucchesi. (2001). Down-regulation by Antisense Oligonucleotides Establishes a Role for the Proline-rich Tyrosine Kinase PYK2 in Angiotensin II-induced Signaling in Vascular Smooth Muscle. Journal of Biological Chemistry. 276(24). 21902–21906. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact